REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 109 filers reported holding REPLIMUNE GROUP INC in Q2 2021. The put-call ratio across all filers is 4.61 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,465,703 | -18.0% | 1,430,025 | +11.3% | 0.01% | -20.0% |
| Q2 2023 | $29,824,541 | +56.9% | 1,284,449 | +19.3% | 0.01% | +66.7% |
| Q1 2023 | $19,010,269 | +96178.9% | 1,076,483 | +48.3% | 0.01% | 0.0% |
| Q4 2022 | $19,745 | -99.8% | 725,888 | +12.1% | 0.01% | +50.0% |
| Q3 2022 | $11,178,000 | +35.2% | 647,356 | +36.8% | 0.00% | +33.3% |
| Q2 2022 | $8,269,000 | +41.4% | 473,056 | +37.4% | 0.00% | +50.0% |
| Q1 2022 | $5,848,000 | -7.2% | 344,397 | +48.1% | 0.00% | 0.0% |
| Q4 2021 | $6,301,000 | +21.2% | 232,477 | +32.6% | 0.00% | 0.0% |
| Q3 2021 | $5,198,000 | +100.2% | 175,360 | +159.6% | 0.00% | +100.0% |
| Q2 2021 | $2,596,000 | +155.0% | 67,552 | +102.8% | 0.00% | – |
| Q1 2021 | $1,018,000 | -19.1% | 33,310 | +1.4% | 0.00% | – |
| Q4 2020 | $1,258,000 | +66.2% | 32,856 | 0.0% | 0.00% | – |
| Q3 2020 | $757,000 | +138.8% | 32,856 | +157.6% | 0.00% | – |
| Q2 2020 | $317,000 | – | 12,755 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,001,319 | $51,352,568 | 47.17% |
| Atlas Venture Life Science Advisors, LLC | 2,098,300 | $35,901,913 | 5.56% |
| Redmile Group, LLC | 4,163,922 | $71,244,705 | 3.39% |
| Nan Fung Group Holdings Ltd | 184,739 | $3,160,884 | 2.56% |
| GREAT POINT PARTNERS LLC | 638,495 | $10,924,649 | 1.99% |
| ACUTA CAPITAL PARTNERS, LLC | 150,000 | $2,566,500 | 1.72% |
| Ghost Tree Capital, LLC | 250,000 | $4,277,500 | 1.41% |
| Altium Capital Management LP | 155,000 | $2,652,050 | 1.38% |
| ACUTA CAPITAL PARTNERS, LLC | 1,000 | $1,766,000 | 1.18% |
| Camber Capital Management LP | 2,000,000 | $34,220 | 1.13% |